Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Proteasome Inhibitor Therapy for Waldenström's Macroglobulinemia — Meletios A Dimopoulos (2013) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Proteasome Inhibitor Therapy for Waldenström's Macroglobulinemia
Shared by
Meletios A Dimopoulos
Proteasome Inhibitor Therapy for Waldenström's Macroglobulinemia
Article
2013
en
Authors
Meletios A Dimopoulos
ET
Evangelos Terpos
EK
Efstathios Kastritis
Related publications
Article
2023
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia
Eirini Solia
,
Meletios A Dimopoulos
,
Efstathios Kastritis
Article
2018
Proteasome Inhibitors in Waldenström Macroglobulinemia
Efstathios Kastritis
,
Meletios A Dimopoulos
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Chapter in a book
2016
Immunomodulatory Agents and Proteasome Inhibitors in Waldenstrom’s Macroglobulinemia
Steven P. Treon
,
Jorge J. Castillo
,
Efstathios Kastritis
,
Meletios A Dimopoulos
Article
1993
Fludarabine therapy in Waldenström's macroglobulinemia
Meletios A Dimopoulos
,
Susan O’Brien
,
Hagop M. Kantarjian
,
Sherry Pierce
,
Kay Delasalle
,
B Barlogie
,
Raymond Alexanian
,
Michael J. Keating
Chapter in a book
2007
Novel Options of Therapy in Waldenström Macroglobulinemia
Irene M. Ghobrial
,
Anne‐Sophie Moreau
,
Xavier Leleu
,
Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.